imipramine and vasoactive intestinal peptide

imipramine has been researched along with vasoactive intestinal peptide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dunér-Engström, M; Fahrenkrug, J; Fredholm, BB; Larsson, O; Lundberg, JM; Lundblad, L1
Chiba, S; Furukawa, Y; Karasawa, Y; Murakami, M; Narita, M; Ren, LM; Takei, M1

Other Studies

2 other study(ies) available for imipramine and vasoactive intestinal peptide

ArticleYear
Effects of acute and long-term atropine treatment on levels, release and response to VIP and PHI in the submandibular gland of cat and rat.
    Acta physiologica Scandinavica, 1992, Volume: 146, Issue:3

    Topics: Adenylyl Cyclases; Animals; Atropine; Cats; Cyclic AMP; Guanosine Triphosphate; Imipramine; Male; Organ Size; Parasympathetic Nervous System; Peptide PHI; Rats; Rats, Sprague-Dawley; Submandibular Gland; Vasoactive Intestinal Peptide

1992
Cardiac responses to VIP and VIP-ergic-cholinergic interaction in isolated dog heart preparations.
    European journal of pharmacology, 1990, Oct-02, Volume: 187, Issue:1

    Topics: Animals; Dogs; Electric Stimulation; Electrocardiography; Heart; Heart Rate; Imipramine; In Vitro Techniques; Myocardial Contraction; Norepinephrine; Parasympathetic Nervous System; Propranolol; Swine; Tetrodotoxin; Vasoactive Intestinal Peptide

1990